In Europe, the 2024/2025 vaccine composition guidance[0] recommends excluding B/Yamagata, because it hasn't been detected since 2020 and "no longer seems to pose a threat to public health". That doesn't look like "still there-ish".

[0] https://www.ema.europa.eu/en/news/eu-recommendations-2024-20...